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The objective of the present study was to analyze the relationship
between pharmacokinetic parameters of cephalosporine antibiotic
ceftiofur in mammals and the respective body weight (W), using
reported data from different authors. The parameters of interest:
clearance (ClB), volume of distribution at steady state (Vss) and
elimination half-life were correlated across mammal species, as a
function of W using the conventional allometric equation Y=aWb, where
Y is the pharmacokinetic parameter, W is the body weight, a is the
allometric coefficient (intercept) and b is the exponent that describes
the relationship between the pharmacokinetic parameter and W. Our
estimates Cl=0.155W0.82; Vss=1.01W1.03, indicated that the increase in
these parameters with W approximates a linear power relationship with
slopes being specific for the investigated substance. Overall, the
results of this study indicated that it is possible to use allometry to
predict pharmacokinetic variables of ceftiofur based on W of species.
Key words: allometric scaling, ceftiofur, herbivorous mammals,
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INTRODUCTION
Allometric scaling is a common technique for establishing the relationships
between drug disposition and body weight, or organ perfusion rate (Hunter,
2010). It is based on the assumption that there are anatomical, physiological, and
biochemical similarities among animals, which can be described mathematically
(Boxenbaum, 1984). This kind of interspecies correlation is useful for
extrapolation to animals whose access is difficult. The predictive value of
allometry for interspecies scaling of drug pharmacokinetics depends on the
selection of appropriate parameters. The allometric equations generated
separately for parameters such as body clearance and volume of distribution at
steady state for ceftiofur could be applied to generate equivalent values in new
animal species hitherto not tested and/or enable an optimised dose design in new
animal species. This is the reason why the most frequently used pharmacokinetic
parameters are body clearance (ClB), volume of distribution (Vss) and elimination
half life (t1/2) (Cox, 2007).
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investigated in various animal species including most popular domesticated
herbivoroes (Brown et al., 1996; Drew et al., 2004 Errecalde et al., 2006;
Dumokceaux et al., 2005). This prompted us to assess the relationship between
the main pharmacokinetic parameters and body weight across mammal species
for this valuable drug, and to determine the scaling coefficients in those cases
where significant relationships are found.
MATERIALS AND METHODS
Data of published reports about the biological half-life (t1/2), total body
clearance (ClB) and volume of distribution (Vss) of ceftiofur after intravenous
administration in different mammalian species were collected (Table 1).
Table 1. Pharmacokinetic parameters of ceftiofur after intravenous administration to
seven mammal species
Specie
Body
weight
(kg)
t1/2
(h)
ClB
(l/kg/h)
Vss
(l/kg) Reference
Cow
200 15.30 0.013 0.298 Liu et al., 1996
246 5.95 0.039 0.258 Brown et al., 1996
186 5.05 0.029 0.206 El Gendy et al., 2007
500 7.12 0.036 0.253 Whittem et al., 1995
500 5.09 0.026 0.178 Tohamy, 2008
Mean 326.4 7.70 0.029 0.239
Buffalo 247 1.61 0.065 0.134 El Gendy et al., 2007
Goat
35 1.63 0.198 0.380 Errecalde et al., 2006
58 2.86 0.062 0.260 Courtin et al., 1997
Mean 46.5 2.24 0.130 0.320
Sheep 46.1 2.43 Craigmill et al., 1997
Alpaca 72.7 5.60 0.082 0.540 Drew et al., 2004
Llama 123.6 2.19 0.059 0.190 Christensen et al., 1996
Camel 400 3.18 0.030 0.130 Goudah, 2007
Elephant 3530 3.80 0.069 0.510 Dumokceauxetal.,2005
All available publications, where the body weight of experimental animals
was indicated at an age that certified a complete maturation of liver and kidneys,
and where antibiotic concentrations were measured by high-performance liquid
chromatography, were used. All values were transformed in equal dimensions for
eachstudiedparameter(totalbodyclearanceinL/h,thevolumeofdistribution–in
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these pharmacokinetic parameters by species, an analysis of the relationship
between the parameters investigated and the animal's body weight was made.
For this purpose, a regression analysis and the least square method was used.
The equations were from the type: logPhP = c+b.logW, where: PhP – value of the
respective pharmacokinetic parameter; W – body weight; c and b – coefficients
indicating the Y-axis intercept and the slope of the regression curve, respectively.
The equation could be transformed into PhP=a.Wb, where a is the antilogarithm
of c. Coefficients of determination "r" and P-values were calculated for each
correlation.
RESULTS
The allometric relationship between the pharmacokinetic parameters
investigated and W is shown in Table 2. The equation describing the regression of
ClB versus W is ClB=0.155W0.82. A good correlation was registered – r=0.9285,
(p<0.001). A good correlation with W was also observed for Vss. The respective
equation is Vss=0.21W1.03, and the value of "r" was 0.9299 (p<0.001). However,
ceftiofureliminationhalf-lifeasnotrelatedtoW(t1/2=1.96W0.09;r=0.248;p>0.05).
Table 2. Allometric relationship between body clearance, volume of distribution and
elimination half life of ceftiofur and the body mass
Parameters t1/2 (h) ClB (L/h) Vss (L)
a 1.96 0.155 0.21
b 0.09 0.82 1.033
r 0.248 0.9285 0.9299
p >0.05 <0.001 <0.001
a – allometric coefficient, b – allometric exponent, r – correlation coefficient
Table 3. Values of selected pharmacokinetic parameters (observed, predicted and
inaccuracy % for ceftiofur in herbivorous mammal species
Species W (kg)
ClB (L/h) Vss (L)
Calculated Predicted Calculated Predicted
Cattle 326.4 9.47 17.80 (88.5) 78.0 81.5 (4.5)
Buffalo 247 16.10 14.20 (11.8) 33.1 61.2 (84.5)
Goat 46.5 6.05 3.61(40.4) 14.9 11.0 (26.2)
Alpaca 72.7 5.96 5.21 (13.6) 39.3 17.4 (55.7)
Llama 123.6 7.26 8.05 (10.9) 23.5 29.9 (27.2)
Camel 400 12 21.10 (75.7) 52.0 100.5 (93.3)
Elephant 3530 243.6 125.70 (49.4) 1800 947.2 (47.4)
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the increase of their values with W approximates a linear power relationship which
slopes are specific for this substance. Values of selected pharmacokinetic
parameters: observed, predicted and inaccuracy (%) are presented in Table 3.
DISCUSSION
Ceftiofur obeys first order kinetics, low and linear percentage of protein
binding, and mainly renal elimination process (Craigmill et al., 1997; Drew et al.,
2004; Dumokceaux et al., 2005). These pharmacokinetic characteristics are
optimal for adequate allometric analysis for any substance (Mahmood, 2007).
Accordingly we found good correlation between ClB and Vss values of ceftiofur
and body weight. Both values are similar to the ones reported by other authors for
other beta-lactame antibiotics using the same analysis (Matsui et al., 1982;
Mordenti, 1985). The low value of the allometric exponent (0.09) is not consistent
with the reported low degree of correlation of t1/2 with W for other beta-lactame
antibiotics (Mordenti, 1985, Gardner and Papich, 2001).
The present study demonstrated that interspecies scaling of ceftiofur
pharmacokinetics is valuable across mammal species. Elimination half-life is
independent of W, whereas ClB and Vss can be extrapolated using allometric
equations. This would be of help to predict ceftiofur disposition and doses for
species that have not been studied. The differences between calculated and
observed values could be defined as acceptable.
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ALOMETRIJSKA ANALIZA FARMAKOKINETIKE KOD SISARA BILJOJEDA:
STUDIJA CEFTIOFURA
HARITOVA ANELIYA i LASHEV L
SADR@AJ
Cilj ovog istra`ivanja je bila analiza odnosa izme|u farmakokineti~kih para-
metara cefalosporinskog antibiotika ceftiofura kod sisara razli~ite telesne mase
(W). Ispitivani su slede}i parametri: klirens (ClB), volumen distribucije u stanju mi-
rovanja (Vss) i polu`ivot eliminacije. Parametri su upore|ivani kod razli~itih vrsta
sisara, kao funkcija telesne mase primenom konvencionalne alometrijske
jedna~ineY=aWb,gdejeY-farmakokineti~kiparametar,W-telesnamasa,a-alo-
metrijski koeficijent i b - eksponent koji opisuje odnos izme|u farmakokineti~kog
parametra i telesne mase. Vrednosti koje smo mi dobili (Cl=0.155W0.82;
Vss=1.01W1.03) ukazuju da pove}anje ovih parametara sa pove}anjem telesne
mase dosti`e pribli`no linearan odnos sa odstupanjima specifi~nim za ispitivanu
supstancu. Rezultati ovih ispitivanja ukazuju da je mogu}a primena alometrijskog
metoda u predvi|anju farmakokineti~kih varijabli ceftiofura u odnosu na telesnu
masu pojedinih vrsta.
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